InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the full record of transactions filed by Larkin Cristina, Chief Operating Officer. Officer active across 1 company, notably Spero Therapeutics, Inc.. Cumulatively, 2 filings have been recorded. History available since 26 August 2021. The latest transaction was disclosed on 1 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Larkin Cristina
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
38,014 shares0Common StockSEC:0000899243-22-004592:0
24,067 shares0Common StockSEC:0000899243-21-034501:0
2 of 2 declarations
About Larkin Cristina
Cristina Larkin is the Chief Operating Officer at Spero Therapeutics, Inc. She is responsible for the daily management of the company's operations, ensuring that processes are efficient and aligned with strategic objectives. With expertise in operational management, she plays a key role in optimizing performance and supporting innovation within Spero Therapeutics. Her leadership is essential for the company's success.
